|
OMIM |
Link |
Information gain |
01 |
|
nephrolithiasis, calcium oxalate
|
[NCBI]
|
0.00494549
|
|
|
APRT
|
[NCBI]
|
0.000937602
|
|
|
dent disease 1
|
[NCBI]
|
0.000767351
|
|
|
leukonychia totalis
|
[NCBI]
|
0.000715905
|
|
|
XRN
|
[NCBI]
|
0.000662121
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
0.000544084
|
|
|
PTH
|
[NCBI]
|
0.000531807
|
|
|
HCA2
|
[NCBI]
|
0.000489687
|
|
|
SPP1
|
[NCBI]
|
0.000485792
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000394467
|
|
|
UMOD
|
[NCBI]
|
0.000359802
|
|
|
CLCN5
|
[NCBI]
|
0.000293697
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
0.000235159
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
0.000180644
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
0.000173295
|
|
|
VDR
|
[NCBI]
|
0.000167403
|
|
|
hypouricemia, renal
|
[NCBI]
|
0.000150714
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
0.000147626
|
|
|
xanthinuria, type i
|
[NCBI]
|
0.000137595
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
0.000137595
|
|
|
wilson disease
|
[NCBI]
|
0.000130756
|
|
|
tachycardia, hypertension, microphthalmia, and hyperglycinuria
|
[NCBI]
|
0.000117451
|
|
|
CASR
|
[NCBI]
|
0.000102495
|
|
|
glycogen storage disease i
|
[NCBI]
|
8.98252e-05
|
|
|
hypomagnesemia, renal, with ocular involvement
|
[NCBI]
|
8.65192e-05
|
|
|
glycinuria with or without oxalate urolithiasis
|
[NCBI]
|
8.10223e-05
|
|
|
UOX
|
[NCBI]
|
7.36852e-05
|
|
|
steatocystoma multiplex
|
[NCBI]
|
7.36852e-05
|
|
|
ZNF365
|
[NCBI]
|
6.89903e-05
|
|
|
gout, hprt-related
|
[NCBI]
|
6.867e-05
|
|
|
RA
|
[NCBI]
|
6.31403e-05
|
|
|
hyperprolinemia, type i
|
[NCBI]
|
6.0439e-05
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
5.59825e-05
|
|
|
FGF23
|
[NCBI]
|
5.50346e-05
|
|
|
SLE
|
[NCBI]
|
5.31959e-05
|
|
|
CSID
|
[NCBI]
|
5.10224e-05
|
|
|
GACI
|
[NCBI]
|
5.10224e-05
|
|
|
solute carrier family 26 (anion transporter), member 6: slc26a6
|
[NCBI]
|
5.00273e-05
|
|
|
alkaptonuria
|
[NCBI]
|
4.72588e-05
|
|
|
adenylyl cyclase, soluble
|
[NCBI]
|
4.6659e-05
|
|
|
REG1A
|
[NCBI]
|
4.6659e-05
|
|
|
SLC34A3
|
[NCBI]
|
4.6659e-05
|
|
|
SLC34A1
|
[NCBI]
|
4.41569e-05
|
|
|
HPRT1
|
[NCBI]
|
4.07781e-05
|
|
|
GRHPR
|
[NCBI]
|
4.05099e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
3.66932e-05
|
|
|
XDH
|
[NCBI]
|
3.47378e-05
|
|
|
SLC7A9
|
[NCBI]
|
3.40598e-05
|
|
|
LNS
|
[NCBI]
|
3.39594e-05
|
|
|
SDC2
|
[NCBI]
|
3.38759e-05
|
|
|
AMC
|
[NCBI]
|
3.3502e-05
|
|
|
AGXT
|
[NCBI]
|
3.3304e-05
|
|
|
HGD
|
[NCBI]
|
3.3304e-05
|
|
|
MEN2A
|
[NCBI]
|
2.95791e-05
|
|
|
PTHR1
|
[NCBI]
|
2.83109e-05
|
|
|
TFF1
|
[NCBI]
|
2.74835e-05
|
|
|
LOX
|
[NCBI]
|
2.36355e-05
|
|
|
PXE
|
[NCBI]
|
1.57534e-05
|
|
|
BWS
|
[NCBI]
|
1.16245e-05
|
|
|
CF
|
[NCBI]
|
9.7842e-06
|
|
|
EGF
|
[NCBI]
|
7.03471e-06
|
|
|
EPO
|
[NCBI]
|
4.1219e-06
|
|
|
TLR4
|
[NCBI]
|
4.07261e-06
|
|
|
F3
|
[NCBI]
|
4.00166e-06
|
|
|
ALB
|
[NCBI]
|
3.75474e-06
|
|
|
HGF
|
[NCBI]
|
8.94914e-07
|
|
|
PCNA
|
[NCBI]
|
6.75062e-07
|
|
|
ADA
|
[NCBI]
|
2.60489e-07
|
|
|
AVP
|
[NCBI]
|
2.53741e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.43396e-07
|
|
|
NPPA
|
[NCBI]
|
1.26919e-07
|
|
|
CAT
|
[NCBI]
|
6.29734e-08
|
|